APTA vs. EVG, NFX, PYC, FAB, OCTP, IXI, VAL, BSFA, GENF, and ROQ
Should you be buying Aptamer Group stock or one of its competitors? The main competitors of Aptamer Group include Evgen Pharma (EVG), Nuformix (NFX), Physiomics (PYC), Fusion Antibodies (FAB), Oxford Cannabinoid Technologies (OCTP), IXICO (IXI), ValiRx (VAL), BSF Enterprise (BSFA), Genflow Biosciences (GENF), and Roquefort Therapeutics (ROQ). These companies are all part of the "biotechnology" industry.
Evgen Pharma (LON:EVG) and Aptamer Group (LON:APTA) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their community ranking, risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability.
Aptamer Group's return on equity of -60.57% beat Evgen Pharma's return on equity.
Evgen Pharma has higher earnings, but lower revenue than Aptamer Group. Evgen Pharma is trading at a lower price-to-earnings ratio than Aptamer Group, indicating that it is currently the more affordable of the two stocks.
Evgen Pharma has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500. Comparatively, Aptamer Group has a beta of -0.42, suggesting that its stock price is 142% less volatile than the S&P 500.
Evgen Pharma received 193 more outperform votes than Aptamer Group when rated by MarketBeat users.
In the previous week, Aptamer Group's average media sentiment score of 0.00 equaled Evgen Pharma'saverage media sentiment score.
26.6% of Evgen Pharma shares are owned by institutional investors. Comparatively, 1.5% of Aptamer Group shares are owned by institutional investors. 40.3% of Evgen Pharma shares are owned by insiders. Comparatively, 25.6% of Aptamer Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
Summary
Evgen Pharma beats Aptamer Group on 7 of the 10 factors compared between the two stocks.
Get Aptamer Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for APTA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding APTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aptamer Group Competitors List
Related Companies and Tools
